Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Salivary Gland Adaptation to Dietary Inclusion of Hydrolysable Tannins in Boars. | Animals (Basel) | 2022 | 36077892 | PubTator, text mining | PubMed |
| Cottonseed Meal Protein Isolate as a New Source of Alternative Proteins: A Proteomics Perspective. | Int J Mol Sci | 2022 | 36077502 | PubTator, text mining | PubMed |
| Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma. | Int J Mol Sci | 2022 | 36077307 | PubTator, text mining | PubMed |
| Physical, Mechanical, and Biological Properties of Fibrin Scaffolds for Cartilage Repair. | Int J Mol Sci | 2022 | 36077276 | PubTator, text mining | PubMed |
| Integrated Transcriptome and Proteome Analysis Provides Insight into the Ribosome Inactivating Proteins in Plukenetia volubilis Seeds. | Int J Mol Sci | 2022 | 36076961 | PubTator, text mining | PubMed |
| On-demand, remote and lossless manipulation of biofluid droplets. | Mater Horiz | 2022 | 36070425 | PubTator, text mining | PubMed |
| CD55 Facilitates Immune Evasion by Borrelia crocidurae, an Agent of Relapsing Fever. | mBio | 2022 | 36036625 | PubTator, text mining | PubMed |
Protein S gene mutation c.946C > T (p.R316C) contributed to ischemic stroke in a man with von Willebrand disease type 3 caused by two novel VWF gene mutations, c.2328delT (p.A778Lfs* 23) and c.6521G > T (p.C2174F). | Clin Case Rep | 2022 | 36034607 | PubTator, text mining | PubMed |
| Harnessing Human Papillomavirus' Natural Tropism to Target Tumors. | Viruses | 2022 | 36016277 | PubTator, text mining | PubMed |
| Swiss Medical Devices for Autologous Regenerative Medicine: From Innovation to Clinical Validation. | Pharmaceutics | 2022 | 36015243 | PubTator, text mining | PubMed |
| The Exploration of Complement-Resistance Mechanisms of Pathogenic Gram-Negative Bacteria to Support the Development of Novel Therapeutics. | Pathogens | 2022 | 36015050 | PubTator, text mining | PubMed |
| Functional Characterization of Serum Amyloid P Component (SAP) in Host Defense against Bacterial Infection in a Primary Vertebrate. | Int J Mol Sci | 2022 | 36012731 | PubTator, text mining | PubMed |
| Differential RNA aptamer affinity profiling on plasma as a potential diagnostic tool for bladder cancer. | NAR Cancer | 2022 | 36004048 | PubTator, text mining | PubMed |
| Uncovering the functions of plasma proteins in ulcerative colitis and identifying biomarkers for BPA-induced severe ulcerative colitis: A plasma proteome analysis. | Ecotoxicol Environ Saf | 2022 | 35999755 | PubTator, text mining | PubMed |
| What makes functional amyloids work? | Crit Rev Biochem Mol Biol | 2022 | 35997712 | PubTator, text mining | PubMed |
| New frontiers of tendon augmentation technology in tissue engineering and regenerative medicine: a concise literature review. | J Int Med Res | 2022 | 35983666 | PubTator, text mining | PubMed |
A-kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the ERK/c-Myc signaling pathway by binding to Rac1. | Exp Ther Med | 2022 | 35978938 | PubTator, text mining | PubMed |
| Streptococcus pneumoniae interactions with the complement system. | Front Cell Infect Microbiol | 2022 | 35967850 | PubTator, text mining | PubMed |
| Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation. | Front Immunol | 2022 | 35967376 | PubTator, text mining | PubMed |
| Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition. | Front Immunol | 2022 | 35958597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=27